Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmatrix (PULM) Capital Expenditures (2016 - 2024)

Pulmatrix's Capital Expenditures history spans 11 years, with the latest figure at $244000.0 for Q2 2024.

  • For Q2 2024, Capital Expenditures changed N/A year-over-year to $244000.0; the TTM value through Dec 2024 reached $398000.0, up 14.37%, while the annual FY2024 figure was $398000.0, 2.31% up from the prior year.
  • Capital Expenditures for Q2 2024 was $244000.0 at Pulmatrix, up from $154000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $321000.0 in Q3 2023 and bottomed at $2000.0 in Q2 2020.
  • The 5-year median for Capital Expenditures is $83000.0 (2020), against an average of $94615.4.
  • The largest YoY upside for Capital Expenditures was 860.0% in 2020 against a maximum downside of 92.0% in 2020.
  • A 5-year view of Capital Expenditures shows it stood at $83000.0 in 2020, then crashed by 68.67% to $26000.0 in 2021, then crashed by 65.38% to $9000.0 in 2022, then skyrocketed by 100.0% to $18000.0 in 2023, then skyrocketed by 1255.56% to $244000.0 in 2024.
  • Per Business Quant, the three most recent readings for PULM's Capital Expenditures are $244000.0 (Q2 2024), $154000.0 (Q1 2024), and $18000.0 (Q4 2023).